Paparella MM. Pathogenesis and pathophysiology of Meniere's disease. Acta Otolaryngol Suppl. 1991;485:26-35.
Pulec JL. Meniere's disease. Etiology, natural history, and results of treatment. Otolaryngol Clin North Am 1973;6:25-39.
Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am. 2002;35:529-545.
Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am. 2002;35:621-637.
Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11:430-433.
Hanley PJ, Davis PB, Paki B, et al. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008;117:791-799.
Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 1997;30:1051-1059.
1. Thirlwall AS, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2006;(3):CD003599.
2. da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am. 2002;35:455-495.
3. American Academy of Otolaryngology-Head and Neck Foundation. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg. 1995;113:181-185.
4. Wladislavosky-Waserman P, Facer GW, Mokri B, et al. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope. 1984;94:1098-1102.
5. Paparella MM. Pathogenesis and pathophysiology of Meniere's disease. Acta Otolaryngol Suppl. 1991;485:26-35.
6. Huppert D, Strupp M, Brandt T. Long-term course of Menière's disease revisited. Acta Otolaryngol. 2010;130:644-651.
7. Conlon BJ, Gibson WP. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear. Laryngoscope. 1999;109:1800-1802.
8. Pulec L, House WF. Meniere's disease study: three-year progress report. Int J Equilib Res. 1973;3:156-165.
9. Pulec JL. Meniere's disease. Etiology, natural history, and results of treatment. Otolaryngol Clin North Am 1973;6:25-39.
10. Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am. 2002;35:529-545.
11. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005;26:74-81.
12. Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am. 2002;35:621-637.
13. Selmani Z, Marttila T, Pyykko I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol. 2005;262:331-334.
14. de Sousa LC, Piza MR, da Costa SS. Diagnosis of Meniere's disease: routine and extended tests. Otolaryngol Clin North Am. 2002;35:547-564.
15. Grant IL, Welling DB. The treatment of hearing loss in Meniere's disease. Otolaryngol Clin North Am. 1997;30:1123-1144.
16. Ballester M, Liard P, Vibert D, et al. Meniere's disease in the elderly. Otol Neurotol. 2002;23:73-78.
17. Kentala E, Havia M, Pyykko I. Short-lasting drop attacks in Meniere's disease. Otolaryngol Head Neck Surg. 2001;124:526-530.
18. Lee CS, Paparella MM, Margolis RH, et al. Audiological profiles and Meniere's disease. Ear Nose Throat J. 1995;74:527-532.
19. Gibson WP, Moffat DA, Ramsden RT. Clinical electrocochleography in the diagnosis and management of Meniere's disorder. Audiology. 1977;16:389-401.
20. Ferraro JA, Durrant JD. Electrocochleography in the evaluation of patients with Meniere's disease/endolymphatic hydrops. J Am Acad Audiol. 2006;17:45-68.
21. Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere's disease. Acta Otolaryngol. 2000;120:480-483.
22. Al-momani MO, Ferraro JA, Gajewski BJ, et al. Improved sensitivity of electrocochleography in the diagnosis of Meniere's disease. Int J Audiol. 2009;48:811-819.
23. Ferraro JA. Electrocochleography: a review of recording approaches, clinical applications, and new findings in adults and children. J Am Acad Audiol. 2010;21:145-152.
24. Ferraro J. Electrocochleography. In: Ross JR, Valente M, Hosford-Dunn H, eds. Audiologic diagnosis. 2nd ed. New York, NY: Thieme; 2000:425-450.
25. Gürkov R, Flatz W, Louza J, et al. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011;268:1743-1748.
26. Sano R, Teranishi M, Yamazaki M, et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol. 2012;132:241-246.
27. Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006;19:26-32.
28. Jerger J, Jerger S. Diagnostic significance of PB word functions. Arch Otolaryngol. 1971;93:573-580.
29. Fetterman BL. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops. Laryngoscope. 2001;111:946-954.
30. Young YH, Huang TW, Cheng PW. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2003;129:815-818.
31. Kentala E, Pyykkö I. Vestibular schwannoma mimicking Ménière's disease. Acta Otolaryngol Suppl. 2000;543:17-19.
32. Shepard NT. Differentiation of Meniere's disease and migraine-associated dizziness: a review. J Am Acad Audiol. 2006;17:69-80.
33. Roland PS, Marple BF, Meyerhoff WL, eds. Hearing loss. New York, NY: Thieme Medical Publishers, Inc.; 1997.
34. Karlberg M, Hall K, Quickert N, et al. What inner ear diseases cause benign paroxysmal positional vertigo? Acta Otolaryngol. 2000;120:380-385.
35. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017;156:S1-S47.
36. Baloh RW. The dizzy patient. Postgrad Med. 1999;105:161-164, 167-172.
37. Kinney SE, Sandridge SA, Newman CW. Long-term effects of Meniere's disease on hearing and quality of life. Am J Otol. 1997;18:67-73.
38. Hamill TA. Evaluating treatments for Meniere's disease: controversies surrounding placebo control. J Am Acad Audiol. 2006;17:27-37.
39. Gacek RR, Gacek MR. Menière's disease as a manifestation of vestibular ganglionitis. Am J Otolaryngol. 2001;22:241-250.
40. Rickenstein MJ, Harrison RV. Cochlear pathophysiology in Meniere’s disease: a critical appraisal. In: Harris JP, ed. Ménière’s disease. The Hague, Netherlands: Kugler Publications; 1999:195-202.
41. Boles R, Rice DH, Hybels R, et al. Conservative management of Meniere's disease: Furstenberg regimen revisited. Ann Otol Rhinol Laryngol. 1975;84:513-517.
42. Brown JS. A ten year statistical follow-up of 245 consecutive cases of endolymphatic shunt and decompression with 328 consecutive cases of labyrinthectomy. Laryngoscope. 1983;93:1419-1424.
43. Glasscock ME, Gulya AJ, Pensak ML, et al. Medical and surgical management of Meniere's disease. Am J Otol. 1984;5:536-542.
44. Santos PM, Hall RA, Snyder JM, et al. Diuretic and diet effect on Meniere's disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines. Otolaryngol Head Neck Surg. 1993;109:680-689.
45. Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl. 2000;544:27-33.
46. Nishiyama S, Okada T, Kobayashi T, et al. Na-K-ATPase activity in the guinea pig stria vascularis in experimentally-induced endolymphatic hydrops. Histol Histopathol. 1994;9:205-209.
47. Wright T. Meniere's disease. BMJ Clin Evid. November 2015. http://www.clinicalevidence.bmj.com/ (last accessed 18 March 2017).
48. James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev. 2001;(1):CD001873.
49. Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998;19:196-201.
50. Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11:430-433.
51. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143-148.
52. Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998;9:153-160.
53. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993;27:7-17.
54. Jastreboff PJ, Hazell JWP. Treatment of tinnitus based on a neurophysiological model. In: Vernon J, ed. Tinnitus: treatment and relief. Boston, MA: Allyn & Bacon; 1998:201-216.
55. Davis PB, Paki B, Hanley PJ. Neuromonics Tinnitus Treatment: third clinical trial. Ear Hear. 2007;28:242-259.
56. Hanley PJ, Davis PB, Paki B, et al. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008;117:791-799.
57. Davis PB, Wilde RA, Steed LG, et al. Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J. 2008;87:330-339.
58. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg. 1993;119:842-845.
59. Valente M, Mispagel K, Valente LM, et al. Problems and solutions for fitting amplification to patients with Meniere's disease. J Am Acad Audiol. 2006;17:6-15.
60. Shea JJ, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am. 1996;29:353-358.
61. Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 1997;30:1051-1059.
62. Barrs DM, Keyser JS, Stallworth C, et al. Intratympanic steroid injections for intractable Meniere's disease. Laryngoscope. 2001;111:2100-2104.
63. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol. 2004;25:544-552.
64. Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope. 2004;114:2085-2091.
65. Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008;128:876-880.
66. Stokroos R, Olvink MK, Hendrice N, et al. Functional outcome of treatment of Meniere's disease with the Meniett pressure generator. Acta Otolaryngol. 2006;126:254-258.
67. Gates GA, Verrall A, Green JD, et al. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2006;132:1311-1316.
68. Thomsen J, Sass K, Odkvist L, et al. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005;26:68-73.
69. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2015;(3):CD008419.
70. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015;(1):CD005397.
71. Hansson EE. Vestibular rehabilitation: for whom and how? A systematic review. Adv Physiother. 2007;9:106-116.
72. Gottshall KR, Hoffer ME, Moore RJ, et al. The role of vestibular rehabilitation in the treatment of Meniere's disease. Otolaryngol Head Neck Surg. 2005;133:326-328.
73. Bretlau P, Thomsen J, Tos M, et al. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol. 1989;10:259-261.
74. Pillsbury HC, Arenberg IK, Ferraro J, et al. Endolymphatic sac surgery. The Danish sham surgery study: an alternative analysis. Otolaryngol Clin North Am. 1983;16:123-127.
75. Thomsen J, Bretlau P, Tos M, et al. Meniere's disease: endolymphatic sac decompression compared with sham (placebo) decompression. Ann N Y Acad Sci. 1981;374:820-830.
76. Thomsen J, Bonding P, Becker B, et al. The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol. 1998;118:769-773.
77. Pullens B, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. Cochrane Database Syst Rev. 2013;(2):CD005395.
78. Paparella MM, Sajjadi H. Endolymphatic sac enhancement. Principles of diagnosis and treatment. Am J Otol. 1987;8:294-300.
79. Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin North Am. 2002;35:655-673.
80. Møller MN, Cayé-Tomasen P, Thomsen JH. Vestibular nerve section in the treatment of morbus Ménière [in Danish]. Ugeskr Laeger. 2009;171:1000-1003.
81. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am. 2002;35:675-682.
82. Graham MD, Colton JJ. Transmastoid labyrinthectomy indications. Technique and early postoperative results. Laryngoscope. 1980;90:1253-1262.
83. Lustig LR, Yeagle J, Niparko JK, et al. Cochlear implantation in patients with bilateral Ménière's syndrome. Otol Neurotol. 2003;24:397-403.
84. Pothula VB, Chew F, Lesser TH, et al. Falls and vestibular impairment. Clin Otolaryngol Allied Sci. 2004;29:179-182.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台